Jupiter Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History

Jupiter Asset Management’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-8,536	Closed	-$339K	–	501
2023 Q1	$339K	Sell	8,536 -1,768	-17%	-$74.6K	﹤0.01%	384
2022 Q4	$413K	Hold	10,304	–	–	0.01%	414
2022 Q3	$331K	Hold	10,304	–	–	0.01%	470
2022 Q2	$306K	Hold	10,304	–	–	﹤0.01%	530
2022 Q1	$289K	Buy	+10,304	New	+$384K	﹤0.01%	483

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

Jupiter Asset Management's ANIP Position: Q2 2023 in Review

Jupiter Asset Management sold out of ANI Pharmaceuticals (ANIP) in Q2 2023, closing a stake of 8,536 shares — an estimated $339K sold.

Jupiter Asset Management first reported a position in ANIP in Q1 2022 and held it in 5 quarters. The position peaked at $413K in Q4 2022. 171 funds tracked by Wall St. Rank hold ANIP as of Q2 2023.

Jupiter Asset Management reported no remaining ANI Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
Jupiter Asset Management sold 8,536 ANI Pharmaceuticals shares in Q2 2023, an estimated $339K.
Jupiter Asset Management first reported a position in ANI Pharmaceuticals in Q1 2022 and held it in 5 quarters.
Jupiter Asset Management's ANI Pharmaceuticals position peaked at $413K in Q4 2022.
171 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2023.

Based on Jupiter Asset Management's 13F filing for Q2 2023, filed 10 Aug 2023.